แนวทางการกากับการใช้ยา Trastuzumab ข้อบ่งใช้มะเร็งเ

DRUG NAME: Trastuzumab deruxtecan trastuzumab Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the trastuzumab Trastuzumab injection products may cause serious or life-threatening reactions that may occur while the medication is being given or up to 24

trastuzumab trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients